Skip to main content
EN
Caution:
At present, there are occasional discrepancies in the display of intellectual property rights holders and their representatives. We are working on a solution.
Patent Search
Details
see.ip - Details for HERSTELLUNG VON FAKTOR-XA-DERIVATEN
Details for 2017814267
Up to date per 13.06.2026
Actions
Copy link to European Patent
Download Registration Print
Details
Details for 2017814267
Title / Product Name
HERSTELLUNG VON FAKTOR-XA-DERIVATEN
Status
Granted/Registered
Protection Type
European Patent
(AT-) Application Number
2017814267
EP Publication Number
3472314
E-Number
1389865
Language
EN
PCT Number
US17038169
Publication Date
24.04.2019 A
05.05.2021 B1
Registration Date
05.05.2021
AT Publication Date
15.05.2021
Application Date
19.06.2017
Registration Number
-
Priorities
17.06.2016
US
201662351841 P
IPC
C12N 9/64 20060101AFI20191213BHEP
Maximum Duration of Protection
19.06.2037
Owner
Alexion Pharmaceuticals, Inc.
121 Seaport Boulevard
Boston, MA 02210
US
Representative
Representative
Häupl & Ellmeyer KG, Patentanwaltskanzlei
Mariahilfer Straße 50 (Eingang Kirchengasse 1)
1070 Wien
AT
Inventor
KARBARZ, Mark
c/o Portola Pharmaceuticals Inc. 270 E. Grand Ave. Suite 22
South San Francisco, California 94080
US
CONLEY, Pamela B.
c/o Portola Pharmaceuticals Inc. 270 E. Grand Ave. Suite 22
South San Francisco, California 94080
US
LU, Genmin
c/o Portola Pharmaceuticals Inc. 270 E. Grand Ave. Suite 22
South San Francisco, California 94080
US
Information about Fees
Click here to load the fees